Sign in
ALRN Stock Price, Chart, Stats & News
Aileron Therapeutics, Inc.
Save
45.72M
Market cap
–
Current P/E
–
Forward P/E
ALRN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 50.00% |
Operating margin | -48229.37% |
Pretax margin | -46734.13% |
Net margin | -46734.13% |
Effective tax rate | -0.10% |
ROA | -109.64% |
ROE | -118.68% |
D/E | – |
Interest coverage ratio | – |
ALRN valuation
P/E | – |
P/S | 362.82x |
P/B | 1.20x |
P/CF | -2.65x |
P/FCF | -2.18x |
P/OCF | -2.65x |
PEG | -0.45x |
EV multiple | -0.84x |
About
Aileron Therapeutics, Inc. is a U. S.-based clinical-stage company specializing in chemoprotection oncology. Its primary therapeutic candidate, ALRN-6924, is currently being evaluated across multiple clinical trials for various cancer types.
Similar securities
Based on sector and market capitalization
Report issue